Argenica Therapeutics

Developer of neuroprotective therapeutics for stroke and neural injuries

placeNedlands, Western Australia, Australia calendar_todayFounded 2019 language argenica.com.au

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace steady.

Social engagement

Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.

Recent activity

12 Jun 2026
Product launch
hERG assay (xaranetide)
10 Jun 2026
Milestone
regulatory
25 May 2026
Partnership
Emergency Stroke Organisation Conference (ESOC)
Coming soon